About BigBooster
BigBooster, an accelerator and incubator program founded in 2015, is based in Lyon, France. With a presence in 13 countries, it has supported around 78 startups in sectors like High Tech, Life Sciences. As of Aug 2026, BigBooster has witnessed 5 portfolio exits. Most notable companies in
its portfolio include Phenix, BreezoMeter and MaaT Pharma. The program is backed by a team of 1 people who primarily support startups based in France, Tunisia.
Key Metrics
BigBooster's List of Top Investments
BigBooster has a portfolio of 78 companies. Their most notable investments include Phenix and BreezoMeter.Their portfolio spans across France, Tunisia, Belgium and 10 more locations. They have invested in High Tech, Life Sciences, Enterprise Applications and 24 other sectors. Here is the list of top investments by BigBooster:1. Phenix
Provider of food waste management software solutions for businesses. It connects generators and collectors of second-life items. It allows waste generators, companies, and industries that want to sell off their old items, to connect to agencies that wish to buy these items. These include recycling companies, NGOs, and more.
Key facts about Phenix
- Founded Year: 2014
- Location: Paris (France)
- Stage: Series B
- Total Funding till date: $32.7M
- Employee Count: 564 as on Jul 31, 2026
- Investors: ETF Partners, Danone Manifesto Ventures and 16 Others
- Latest Funding Round: Series B, Sep 24, 2022, $*****
- Highlight: Editors' Pick
2. BreezoMeter
BreezoMeter provides a real-time air quality tracking platform. The big-data analytics platform allows the gathering of data from thousands of sensors worldwide and provides a real-time, location-based map of air pollution levels (with past levels available) at the street level using air pollution dispersion models and analytics. It allows users to plan daily activities, track air quality wherever they are, and get real-time air pollution alerts for important locations together with personalized health recommendations. Also available as an API for commercial use.
Key facts about BreezoMeter
- Founded Year: 2014
- Location: Haifa (Israel)
- Stage: Acquired
- Total Funding till date: $45M
- Employee Count: 19 as on May 31, 2026
- Investors: Hella Ventures, SeedIL Ventures and 19 Others
- Latest Funding Round: Series C, Apr 20, 2021, $*****
- Highlight: Acquired
3. MaaT Pharma
Developer of microbiome therapy for the treatment of intestinal dysbiosis diseases. The company develops the treatment using an autologous intestinal microbiota transplant. Its therapeutic applications are intended for patients suffering from malignant blood diseases or bone infections and taking heavy treatments fostering dysbiosis.
Key facts about MaaT Pharma
- Founded Year: 2014
- Location: Lyon (France)
- Stage: Public
- Total Funding till date: $42.3M
- Employee Count: 86 as on Jul 31, 2026
- Investors: SymBiosis, Skyviews Life Science and 11 Others
- Latest Funding Round: Grant (prize money), Jul 20, 2021, $*****
- Highlight: Public
4. Micropep
Sustainable agriculture solutions using micropeptides to protect global food production. They are developing natural crop protection solutions based on micropeptides, short natural protein molecules that target and regulate plant genes and proteins. They are building the next generation of sustainable solutions for farmers who care about their crops and the future of our planet. This is an agricultural biotech company with a global vision, creating safe, efficient, and sustainable natural solutions to adapt agricultural systems to the impact of climate change. Their proprietary discovery platform combines artificial intelligence, bioproduction, and delivery technologies to address major agronomic challenges. They are committed to working with partners across the globe to launch micropeptide-based biological solutions. This company aims to have a positive social impact by securing the future of tomorrow’s food.
Key facts about Micropep
- Founded Year: 2016
- Location: Toulouse (France)
- Stage: Series B
- Total Funding till date: $64.2M
- Employee Count: 60 as on Jul 31, 2026
- Investors: Sofinnova Partners, Zebra Ventures and 10 Others
- Latest Funding Round: Series B, Sep 26, 2024, $*****
- Highlight: Editors' Pick
5. FineHeart
Developer of an implantable cardiovascular device for treating heart failures. The device provides long-term circulatory assistance. The I.C.O.M.S. (Implantable Cardiac Output Management System) is synchronized to heart innate contraction and helps to manage heart failure disease.
Key facts about FineHeart
- Founded Year: 2010
- Location: Pessac (France)
- Stage: Series C
- Total Funding till date: $51.9M
- Employee Count: 87 as on May 31, 2026
- Investors: Verve Ventures, Broadview Ventures and 16 Others
- Latest Funding Round: Series C, Jan 09, 2026, $*****
- Highlight: Editors' Pick
IPOs and Publicly Listed companies in BigBooster's Portfolio
1 of BigBooster's portfolio company became public - MaaT Pharma. It got listed on the Euronext Exchange (Euronext), in Nov 2021 at marketcap of $149MHere are BigBooster's portfolio companies that went public:
Filter this listCompany | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 08, 2021 | - | - | 6821 |
Acquired companies in BigBooster's Portfolio
4 companies from BigBooster's portfolio have been acquired. The most recent acquisition was Matawan in Dec 2025 by Antin Infrastructure Partners for $*****.Here are BigBooster's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 01, 2025 | - | - | 7926 | |
Oct 18, 2023 | - | - | 9929 | |
Sep 20, 2022 | - | - | 7681 | |
Jul 08, 2020 | - | - | 7077 |
